---
schema_version: "secwatch.filing_event.v1"
accession: "0001200375-22-000037"
form_type: "8-K"
ticker: "CDXS"
cik: "0001200375"
company_name: "CODEXIS, INC."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T08:07:44.249433+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Codexis Q3 2022 revenue $34.5M, net loss $10.0M; reaffirms FY2022 guidance

## Summary
- Total Q3 revenue $34.5M, down 6% YoY from $36.8M; net loss $10.0M ($0.15/share) vs net income $2.2M in Q3 2021.
- Product revenue $28.0M, down 2%; excluding COVID drug (PAXLOVID) sales, product revenue up 53% to $15.1M.
- Reiterated FY2022 guidance: total revenue $135-141M, product revenue $112-118M (incl ~$75M from Pfizer).
- New CEO Dr. Stephen Dilly, COO Kevin Norrett, GC Margaret Fitzgerald appointed; Rahul Singhvi added to Board.
- Cash and equivalents $108.7M; expects cash to fund operations through at least end of 2024.

## SEC filing metadata
- accession: 0001200375-22-000037
- form_type: 8-K
- ticker: CDXS
- cik: 0001200375
- company_name: CODEXIS, INC.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1200375/000120037522000037/0001200375-22-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1200375/000120037522000037/cdxs-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001200375-22-000037
- JSON: https://secwatch.observer/filing/0001200375-22-000037.json
- Plain text: https://secwatch.observer/filing/0001200375-22-000037.txt

## Key facts
- Earnings Releases
  CODEXIS, INC. reported third quarter ended September 30, 2022 results: revenue $34.5 million, net income $(10.0) million, or $0.15 per share, EPS $0.15 per share. Guidance reaffirmed.
  - Period: third quarter ended September 30, 2022
  - Revenue: $34.5 million
  - Net income: $(10.0) million, or $0.15 per share
  - EPS: $0.15 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total revenues for the third quarter 2022 were $34.5 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1200375/000120037522000037/0001200375-22-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.